日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association

评估新型心血管疾病风险模型、生物标志物和工具的预测和临床实用性的标准:美国心脏协会科学声明

Khan, Sadiya S; Greenland, Philip; Hayman, Laura L; Khera, Rohan; Navar, Ann Marie; Pencina, Michael J; Reza, Nosheen; Shah, Svati H; Shanbhag, Sujata; Weber, Brittany; Wong, Sally; Khera, Amit

Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program

改善心力衰竭护理质量的最初二十年:遵循指南-心力衰竭计划

Tang, Amber B; Li, Shen; Li, Yilun; Zhao, Juan; Thomas, Kathie; Lewsey, Sabra C; Heidenreich, Paul A; Greene, Stephen J; Allen, Larry A; Jessup, Mariell; Bolles, Michele; Rutan, Christine; Navar, Natalie; Yancy, Clyde W; Fonarow, Gregg C

Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults

2025年AHA/ACC高血压指南对美国成年人开始和加强降压药物治疗的影响

Sayed, Ahmed; Peterson, Eric D; Navar, Ann Marie

Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement

临床医生在血脂管理方面存在差异,影响动脉粥样硬化性心血管疾病的二级预防:这为改进实践提供了契机

Nguyen, Danh Q; Hwang, Jimin; Rohatgi, Anand; Joshi, Parag H; Khera, Amit; Peterson, Eric D; Navar, Ann Marie

Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USA

美国成年人动脉粥样硬化性心血管疾病、慢性肾脏疾病和全身炎症的患病率和特征

Nanna, Michael G; Sloan, Lance A; Navar, Ann Marie; Faurby, Mads D; Husemoen, Lise Lotte N; Paul, Riyanka; Tombak, Gamze; Sattar, Naveed

Cardiovascular Testing and Changes in Lipid-Lowering Therapy After Coronary Artery Calcium Scoring

冠状动脉钙化评分后心血管检查和降脂治疗的变化

Wong, Willis Y; Xie, Luyu; Chan, Pamela; Nguyen, Danh Q; Joshi, Parag H; Khera, Amit; Rohatgi, Anand; Peterson, Eric D; Navar, Ann Marie

Using the PREVENT Equations to Guide Aspirin Use for Primary Prevention of Cardiovascular Disease

利用 PREVENT 方程式指导阿司匹林在心血管疾病一级预防中的应用

Sayed, Ahmed; Peterson, Eric D; Khera, Amit; Virani, Salim S; Navar, Ann Marie

Clinical assessment and interpretation of dysarthria in ALS using attention based deep learning AI models

利用基于注意力机制的深度学习人工智能模型对ALS患者的构音障碍进行临床评估和解读

Merler, Michele; Agurto, Carla; Peller, Julian; Roitberg, Esteban; Taitz, Alan; Trevisan, Marcos A; Navar, Indu; Berry, James D; Fraenkel, Ernest; Ostrow, Lyle W; Cecchi, Guillermo A; Norel, Raquel

Patient Portal Use Among Admitted Surgical Patients Following the 21st Century Cures Act

《21世纪治愈法案》实施后,住院外科患者对患者门户网站的使用情况

Bain, Andrew P; Heslin, Ryan; Matthews, Lynley; Ji, Hongzhao; Moore, Carrie B; Higashi, Robin T; Louissaint, Jeremy; McDonald, Samuel A; Navar, Ann Marie; Willett, DuWayne; Steitz, Brian D; Turer, Robert W

Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus

皮肤红斑狼疮患者动脉粥样硬化性心血管疾病的发病率和患病率

Chen, Henry W; Liu, Jialiang; Yang, Donghan M; Xie, Yang; Peterson, Eric D; Navar, Ann Marie; Chong, Benjamin F